NCT06394310

Brief Summary

The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from traditional acupuncture as it focuses on treating or managing muscle spots, aiming to reduce muscle stiffness and pain. Dry needling may offer a minimally-invasive and medication-free approach to improve muscle spasticity. The investigators hope to see if dry needling also helps enhance balance and walking abilities. This might provide potential improvements inoverall mobility and balance.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

1.2 years

First QC Date

April 26, 2024

Last Update Submit

June 5, 2025

Conditions

Keywords

multiple sclerosisDry needlingSpasticityMobilityBalance

Outcome Measures

Primary Outcomes (1)

  • Spasticity

    Spasticity will be assessed through the Modified Ashworth scale (Scored between 0 to 4, with higher scores show higher level of spasticity)

    5 weeks

Study Arms (2)

Dry needling

EXPERIMENTAL

Participants will complete three sessions of dry needling through three weeks (one session per each week)

Device: Dry needling

Sham DN

SHAM COMPARATOR

Participants randomized to the control group will be receiving sham needling

Device: Sham dry needling

Interventions

The dry needling technique will employ in the current proposed study follows the standard technique for needling patients with spasticity

Dry needling

In the control group, The investigators will use the methods proposed by Cushman et al. to apply sham dry needling (DN) to our participants

Sham DN

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 64 years
  • Clinical diagnosis of Multiple Sclerosis based on the McDonald Criteria
  • Spasticity in their lower legs
  • Patient Determined Disease Steps (PDDS) score of 5 or below

You may not qualify if:

  • Inability to communicate effectively with study personnel
  • Needle phobia
  • Severe varicose veins
  • Presence of an active implanted device
  • Pregnancy
  • Any active cancer or history within 1 year
  • known or suspected infection at the site of needling or in the surrounding area
  • Presence of a fixed plantarflexion contracture at the ankle
  • Acute fracture of dislocation in the region (bilateral lower extremity)
  • Deep vein thrombosis or peripheral vascular disease
  • Thrombophlebitis, or active osteomyelitis in the region (bilateral lower extremity)
  • Any medication changes, including antispastic medicines, for the past three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mobility and Falls Lab

Kansas City, Kansas, 66103, United States

RECRUITING

MeSH Terms

Conditions

Multiple SclerosisMuscle Spasticity

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Abbas TABATABAEI, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 1, 2024

Study Start

May 1, 2024

Primary Completion

July 2, 2025

Study Completion

August 1, 2025

Last Updated

June 11, 2025

Record last verified: 2025-06

Locations